Previous 10 | Next 10 |
Rapid Micro Biosystems, Inc. (RPID) Q4 2022 Results Conference Call March 03, 2023 8:30 AM ET Company Participants Mike Beaulieu - VP, IR & Corporate Communications Rob Spignesi - President, CEO Sean Wirtjes - CFO Conference Call Participants Dan Arias ...
Rapid Micro Biosystems press release ( NASDAQ: RPID ): Q4 GAAP EPS of -$0.39 misses by $0.03 . Revenue of $4.37M (-16.1% Y/Y) misses by $0.13M . For the full year 2023, the Company expects commercial revenue of at least $22.0 million, including the placement of at le...
Reports fourth quarter 2022 commercial revenue of $4.4 million Reports full year 2022 commercial revenue of $17.1 million Delivered full year 2022 recurring commercial revenue of $11.0 ...
LOWELL, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
LOWELL, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
Rapid Micro Biosystems ( NASDAQ: RPID ) expects to report total commercial revenue of $4.2M-$4.4M for the fourth quarter of 2022. Analysts estimate the life sciences technology company to generate $4.5M in revenue. For full year 2022, total commercial revenue is projected between ...
Full year 2022 commercial revenue expected to be between $17.0 million and $17.2 million Finished 2022 with approximately $140 million in cash and investments providing runway at least into 2026 Company to Present at the 41 st Annual J.P. Morgan Healt...
LOWELL, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
LOWELL, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company, providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcar...
LOWELL, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
News, Short Squeeze, Breakout and More Instantly...
Rapid Micro Biosystems Inc. Company Name:
RPID Stock Symbol:
NASDAQ Market:
Rapid Micro Biosystems Inc. Website:
LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...